Quantessence Capital LLC Protara Therapeutics, Inc. Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
A detailed history of Quantessence Capital LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 10,188 shares of TARA stock, worth $35,454. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,188Holding current value
$35,454% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
28.4MCall Options Held
365KPut Options Held
108K-
Janus Henderson Group PLC London, X03.79MShares$13.2 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.4MShares$11.8 Million0.3% of portfolio
-
Blackstone Inc New York, NY1.74MShares$6.07 Million0.03% of portfolio
-
Opaleye Management Inc. Boston, MA1.73MShares$6.02 Million2.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA1.67MShares$5.8 Million12.25% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $39.2M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...